loading

Endra Life Sciences Inc Azioni (NDRA) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
90.74%
2.7805
1.4578 3.1291 2.9946 2.9393
Depreciation and Amortization
30.10%
0.0153
0.0219 - - -
Operating Income/Loss
90.74%
-2.7805
-1.4578 -3.1291 -2.9946 -2.9393
Income/Loss From Continuing Operations Before Tax
90.18%
-2.7757
-1.4595 -3.1008 -2.5571 -2.9427
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
90.18%
-2.7757
-1.4595 -3.1008 -2.5571 -2.9427
Net Income/Loss
290.18%
2.7757
-1.4595 -3.1008 -2.5571 -2.9427
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
5.5514
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
diagnostics_research DGX
$172.56
price up icon 4.80%
diagnostics_research WAT
$321.00
price up icon 1.26%
diagnostics_research LH
$217.63
price up icon 2.63%
$144.67
price up icon 2.80%
diagnostics_research MTD
$988.31
price up icon 1.77%
diagnostics_research IQV
$139.48
price down icon 1.42%
Capitalizzazione:     |  Volume (24 ore):